Literature DB >> 25477425

High frequency of active HCV infection among seropositive cases in west Africa and evidence for multiple transmission pathways.

Jennifer E Layden1, Richard O Phillips2, Shirley Owusu-Ofori3, Fred Stephen Sarfo2, Stephanie Kliethermes1, Nallely Mora4, Dorcas Owusu3, Kenrad Nelson5, Ohene Opare-Sem2, Lara Dugas4, Amy Luke4, David Shoham4, Joseph C Forbi6, Yury E Khudyakov6, Richard S Cooper4.   

Abstract

BACKGROUND: Sub-Saharan Africa (SSA) has one of the highest global hepatitis C virus (HCV) prevalence estimates. However, reports that suggest high rates of serologic false positives and low levels of viremia have led to uncertainty regarding the burden of active infection in this region. Additionally, little is known about the predominant transmission risk factors in SSA.
METHODS: We prospectively recalled 363 past blood donors (180 who were rapid screen assay [RSA] positive and 183 who were RSA negative at time of donation) to identify the level of active infection and risk factors for infection at a teaching hospital in Kumasi, Ghana. Participants had repeat blood testing and were administered a questionnaire on risk factors.
RESULTS: The frequency of HCV active infection ranged from 74.4% to 88% depending on the criteria used to define serologically positive cases. Individuals with active disease had biochemical evidence of liver inflammation and median viral loads of 5.7 log copies/mL. Individuals from the northern and upper regions of Ghana had greater risks of infection compared with participants from other areas. Additional risk factors included traditional circumcision, home birth, tribal scarring, and hepatitis B virus coinfection.
CONCLUSIONS: Viremic infection was common among serologically confirmed cases. Attention to testing algorithms is needed in order to define the true HCV burden in SSA. These data also suggest that several transmission modes are likely contributing to the current HCV epidemic in Ghana and that the distribution of these practices may result in substantial regional variation in prevalence.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Africa; HCV; prevalence; transmission

Mesh:

Year:  2014        PMID: 25477425     DOI: 10.1093/cid/ciu965

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  7 in total

1.  The Prevalence of Hepatitis C Virus Antibody in HIV-Negative Persons in Kenya, 2007.

Authors:  Kathleen N Ly; Andrea A Kim; Jan Drobeniuc; Maja Kodani; Joel M Montgomery; Barry S Fields; Eyasu H Teshale
Journal:  Am J Trop Med Hyg       Date:  2018-04-19       Impact factor: 2.345

2.  A re-evaluation of the origin of hepatitis C virus genotype 2 in West Africa.

Authors:  Michael A Purdy; Joseph C Forbi; Amanda Sue; Jennifer E Layden; William M Switzer; Ohene K Opare-Sem; Richard O Phillips; Yury E Khudyakov
Journal:  J Gen Virol       Date:  2015-04-17       Impact factor: 3.891

3.  Next-Generation Sequencing Reveals Frequent Opportunities for Exposure to Hepatitis C Virus in Ghana.

Authors:  Joseph C Forbi; Jennifer E Layden; Richard O Phillips; Nallely Mora; Guo-Liang Xia; David S Campo; Michael A Purdy; Zoya E Dimitrova; Dorcas O Owusu; Lili T Punkova; Pavel Skums; Shirley Owusu-Ofori; Fred Stephen Sarfo; Gilberto Vaughan; Hajung Roh; Ohene K Opare-Sem; Richard S Cooper; Yury E Khudyakov
Journal:  PLoS One       Date:  2015-12-18       Impact factor: 3.240

4.  Hepatitis C in Uganda: Identification of infected blood donors for micro-elimination.

Authors:  Joan Nankya-Mutyoba; Betty S Apica; Grace Otekat; Dorothy B Kyeyune; Lourita Nakyagaba; Joletta Nabunje; Mary Nakafeero; Emmanuel Seremba; Ponsiano Ocama
Journal:  J Virus Erad       Date:  2021-05-11

5.  Absence of Active Hepatitis C Virus Infection in Human Immunodeficiency Virus Clinics in Zambia and Mozambique.

Authors:  Gilles Wandeler; Lloyd Mulenga; Michael Hobbins; Candido Joao; Edford Sinkala; Jonas Hector; Musa Aly; Benjamin H Chi; Matthias Egger; Michael J Vinikoor
Journal:  Open Forum Infect Dis       Date:  2016-03-02       Impact factor: 3.835

6.  Increased levels of circulating IL-10 in persons recovered from hepatitis C virus (HCV) infection compared with persons with active HCV infection.

Authors:  Dorcas Ohui Owusu; Richard Phillips; Michael Owusu; Fred Stephen Sarfo; Margaret Frempong
Journal:  BMC Res Notes       Date:  2020-10-07

7.  HCV Diagnosis and Sequencing Using Dried Blood Spots from Patients in Kinshasa (DRC): A Tool to Achieve WHO 2030 Targets.

Authors:  Teresa Carrasco; David Barquín; Adolphe Ndarabu; Mirian Fernández-Alonso; Marina Rubio-Garrido; Silvia Carlos; Benit Makonda; África Holguín; Gabriel Reina
Journal:  Diagnostics (Basel)       Date:  2021-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.